MondayOct 06, 2014 1:22 pm

Cannabics Pharmaceuticals Inc. (CNBX) Putting Bio-technology in a Blooming Traditional Industry

It’s common knowledge that law tends to trail technology and social movements, sometimes by years, sometimes by decades. The process of getting new ideas codified in clear and workable legislation can be a long and arduous path, often spotted with periods of contradictory or inconsistently enforced regulations. Nevertheless, after a certain amount of trial and error, the dust eventually settles, issues get clarified, and real changes can take effect. The mounting pressure to allow the use of cannabinoids for the palliative treatment of patients with cancer and other diseases has begun to open the door to a multi-billion dollar market…

Continue Reading

WednesdayOct 01, 2014 1:03 pm

Cannabics Pharmaceuticals, Inc. (CNBX) is “One to Watch”

Cannabics Pharmaceuticals was founded in 2012 by a group of molecular biology, cancer therapy and pharmacology researchers who recognized the potential of cannabinoid-based therapies for debilitating and incurable ailments. Through the course of its research, the company’s pharmacology team has amassed valuable knowledge in the development of advanced delivery systems for active cannabinoids that provide improved treatment options for patients wishing to utilize the unique medical properties of the cannabis plant. Leveraging this expertise and knowledge, Cannabics Pharmaceuticals has created a wide range of solutions for standardized, reproducible and easily administered medical cannabis therapies. The company’s flagship product, Cannabics SR,…

Continue Reading

FridaySep 26, 2014 11:04 am

Cannabics Pharmaceuticals, Inc. (CNBX) Achieves GMP Compliance, Announces Preparation of Clinical Study

Cannabics Pharmaceuticals today announced that it has attained Good Manufacturing Practices (GMP) capabilities. Additionally, the company reported it is moving toward the launch of its first clinical study of Cannabics SR capsules. GMP regulations are designed to ensure that products are produced and controlled according to quality standards. Adhering to these practices ranks Cannabics' products among a very limited number of medical cannabis products available in the U.S. market that are manufactured according to GMP standards. Cannabics' Chief Technology Officer Dr. Eyal Ballan stated, "We're proud to announce GMP standing as we prepare for the upcoming launch of our Cannabics…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered